Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Guardant Health gets EU CDx approval for Guardant360 CDx
Guardant Health received CE-marking for Guardant360 CDx in Europe as a companion diagnostic to identify ER+, HER2- advanced breast cancer patients for AstraZeneca’s camizestrant, after prior approvals in the U.S. and Japan.